Summary & Overview
HCPCS G9368: High-Risk Medication Orders Not Ordered
HCPCS Level II code G9368 denotes instances where at least two orders for high-risk medications from the same drug class were not placed. Nationally, this code signals attention to medication safety processes and decision-support workflows that can prevent unsafe prescribing patterns. Its use reflects clinical judgment, electronic health record alerts, or pharmacy interventions that result in withholding multiple high-risk orders within the same class.
Key payers in national analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on where this code applies clinically, typical sites of service, and how payers may view claims that document medication-nonordering for safety reasons. The publication covers benchmarks and utilization patterns when available, relevant policy and coding guidance changes, and operational considerations for documentation and claims submission.
The material is intended to help health system administrators, coding and billing staff, and clinical leaders understand the purpose and implications of G9368, how it fits into medication-safety workflows, and what to expect in payer interactions and reporting.
Billing Code Overview
HCPCS Level II code G9368 indicates that at least two orders for high-risk medications from the same drug class were not ordered. This code represents a clinical safety concern related to medication management where multiple contemplated prescriptions within a single high-risk drug class were not executed.
-
Service type: Medication safety / clinical decision support intervention
-
Typical site of service: Inpatient and outpatient clinical settings where medication ordering is reviewed (for example, hospitals, emergency departments, and ambulatory clinics)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult inpatient on a medical ward or in a skilled nursing facility who has multiple comorbidities such as chronic pain, anxiety disorders, or insomnia. During medication reconciliation, the treating clinician identifies two or more orders for medications from the same high‑risk drug class (for example, two benzodiazepines or two opioids) that were placed concurrently or within the same ordering episode. The pharmacist or prescribing clinician applies the safety rule represented by G9368 to document that at least two orders for high‑risk medications from the same drug class were not ordered to avoid duplication and mitigate risk of adverse events (oversedation, respiratory depression, drug interactions). Typical workflow: medication reconciliation or computerized provider order entry (CPOE) review → clinical pharmacist or prescriber identifies potential duplicate high‑risk class orders → clinician documents the discontinuation or non‑ordering action in the medical record with supporting rationale and timing → coder assigns G9368 to indicate the safety action. Typical site of service is inpatient acute care units, observation units, emergency departments, or skilled nursing facilities where active medication management and reconciliation occur.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |